Stock Information
Investor and Media Relations
Anthony Marciano
Head of Corporate Communications
Seelos Therapeutics, Inc.
anthony.marciano@seelostx.com
Offices
Seelos Therapeutics, Inc.
300 Park Avenue
New York, NY 10022
Incorporated
Nevada
Entity type
Corporation
Identifiers
CIK:1017491
IRS:870449967
Receive Email Alerts
Seelos Sitemap
Overview
Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused on achieving the most efficient development of products that address significant unmet needs in CNS disorders and in rare diseases.
Seelos Therapeutics Corporate Presentation
Press Releases
Stock Price Chart
Please review our Privacy Policy, Terms of Use, and Accessibility information located at the bottom of this page.